• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0101
Device Problems Difficult To Position (1467); Device Damaged by Another Device (2915)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/22/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
This report is filed as steerable guide catheter advancement resulted in the pacemaker lead to be pulled from the right atrium into the left atrium, requiring intervention.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4+.During the transeptal puncture the transeptal puncture sheath interacted with the right pacemaker lead, located in the right atrium.Following, the steerable guide catheter (sgc) was advanced into the right atrium, which still contained the right atrium pacemaker lead.While advancing the sgc from the right atrium into the left atrium, the pacemaker lead was accidently pulled with the device into the left atrium.The procedure continued, and 2 mitraclips were implanted without issue.Post procedure, a snare was used to pull the pacemaker lead back into the right atrium without any damage noted.The mitraclip procedure had successful results, reducing the mr to 1-2.There were no adverse patient effects and there was no clinically significant delay.There was no additional information provided.
 
Manufacturer Narrative
(b)(4).As the device was not returned for evaluation, a failure analysis of the complaint device could not be performed.In addition, a review of the lot history record and complaint history for the reported lot could not be conducted because the lot number was not provided.The analysis of this complaint was an assessment of the information provided to abbott vascular.Difficulty positioning the device (device entanglement) resulting in damage to the pacemaker may be influenced by anatomical morphology/pathology, such as vessel tortuosity, a rotated heart etc.The information provided in the case details stated that the patient did not have a challenging anatomy; however, the patient had a pacemaker.Therefore, this information suggests that the patient morphology/pathology may have contributed to the reported difficulty positioning the device resulting in the device damaged by another due to the user having a pacemaker.Factors related to user technique/procedural condition which can influence the reported difficulty positioning the sgc (entanglement) resulting in the damage to the pacemaker include, but are not limited to, excessive force applied to advance the sgc forward, advancing the sgc with suboptimal visualization.As per the information provided, the transeptal puncture sheath interacted with the right pacemaker lead, located in the right atrium.Following, the sgc advanced into the right atrium, still containing the right atrium pacemaker lead.It was further reported that while advancing the sgc from the right atrium into the left atrium, the pacemaker lead was accidently pulled with the device into the left atrium.This information suggests that the user technique/procedural circumstances contributed to the reported event of difficulty positioning the device (device entanglement) resulting in damage to the pacemaker.All available information was investigated and the reported difficulty positioning the device (device entanglement) resulting in damage to the pacemaker appears to be related to patient morphology/pathology and user technique/procedural circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
MENLO PARK, CA REG# 3005070406
abbott vascular
26531 ynez rd.
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key5001063
MDR Text Key22884013
Report Number2024168-2015-04610
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K112239
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Remedial Action Other
Report Date 09/18/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberSGC0101
Device Lot Number505057206
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/14/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age86 YR
Patient Weight75
-
-